Neonious Biotech

Neonious Biotech

Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
Pre-ICO
25 de mai. de 2021
31 de out. de 2021
100% completou
Fundos arrecadados - sem dados
objetivo 250 000.00 USD
Boné 30 000 000.00 USD
past
  • 1 MDSIM
    =
    0.1 USD
Detalhes do token
Ticker
MDSIM
Oferta total
125000000
Distribuição de Token
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
Moedas Aceitas
ETH, USDC
Contribuição mínima
250000
USD
Detalhes da Companhia
Nome da empresa registrada
Neonious Biotech
País registrado
Germany
Estrutura de bônus
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
detalhes adicionais
MVP / Protótipo
sim
Plataforma
Ethereum
Países restritos
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
Categorias
Plataforma

Sobre Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

Informações técnicas

https://github.com/neonious/WelcomeToCodeRepository

% name% Roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • consulte Mais informação
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Neonious Biotech Equipe

Verificado 0%

Atenção. Existe o risco de os membros não verificados não serem realmente membros da equipe

Thomas Rogg
Chief Executive Officer & Head of Development Team
não verificado
Elena Elgina
Head of PR & Marketing
não verificado
Maria Cristina Fadgy...
Head of Scientific Affairs
não verificado
Martin Kämpf
Head of Digital Assets
não verificado

Neonious Biotech Últimas notícias

  • Como pode haver diferenças de horário nas atualizações de informações, informações precisas sobre cada projeto da OIC devem ser verificadas por meio de seu site oficial ou de outros canais de comunicação.
  • Esta informação não é uma sugestão ou conselho para investir no financiamento da OIC. Por favor, investigue completamente as informações relevantes e decida sobre a participação da OIC.
  • Se você acha que há problemas ou problemas a serem corrigidos neste conteúdo, ou se gostaria de enviar seu próprio projeto da OIC para ser listado, envie-nos um e-mail. um>
Leia o aviso e o aviso de risco. Mostrar aviso legal e aviso de risco.